New autoantibody specificities in systemic sclerosis and very early systemic sclerosis

HIGHLIGHTS

• who: Roberto Lande et al. from the Department of Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome, ItalyDipartimento, University Sapienza have published the paper: New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis, in the Journal: Antibodies 2021, 10, 12. of /2021/
• what: The authors show that anti-CXCL4-L1 autoantibodies also behave as SSc biomarkers.
• how: These results reinforce the assumption that anti-CXCL4 autoantibodies are qualitatively different Antibodies 2021 10 x FOR PEER REVIEW 9 of 13 between the first disease manifestations and late disease stages. are reported as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.